AusTrials Taringa
Welcome,         Profile    Billing    Logout  
 4 Trials 
17 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith, Jennifer D
NCT03626688 / 2018-001187-33: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Recruiting
3
1000
Europe, Canada, US, RoW
Ralinepag, APD811, Placebo
United Therapeutics
PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease
12/25
12/25
NCT04809376: Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

Active, not recruiting
2/3
602
US, RoW
Pentosan Polysulfate Sodium twice weekly, PPS twice weekly, Placebo (Sodium Chloride Injection, 0.9%), Placebo, Pentosan Polysulfate Sodium Fixed Dose, Fixed Dose, Pentosan Polysulfate Sodium once weekly, PPS once weekly
Paradigm Biopharmaceuticals USA (INC)
Osteoarthritis, Knee
10/24
01/25
ASLAN004-003, NCT05158023: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Completed
2
302
Europe, Canada, US, RoW
Placebo Comparator, ASLAN004
ASLAN Pharmaceuticals
Atopic Dermatitis
06/23
09/23
NCT05399368: An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

Terminated
2
229
Canada, US
RPT193, Placebo
RAPT Therapeutics, Inc.
Atopic Dermatitis
05/24
05/24
MACAWS, NCT06354751: Maternity Care Experiences of Asylum-seeking and Refugee Women in Scotland

Recruiting
N/A
300
Europe
University of Aberdeen
Refugee, Asylum-seeking Women, Maternity
04/25
11/26
NCT06662279: Hyrax Vs. Invisalign Palatal Expander Clinical Study

Recruiting
N/A
36
US
Removable Rapid Palatal Expander, Banded Palatal Expander
Align Technology, Inc.
Malocclusions, Narrow Maxilla, Narrow Maxillary Arch, Crowding
11/25
01/26
MISSION-CJ, NCT04523337: for Justice-Involved Homeless Veterans

Active, not recruiting
N/A
134
US
Maintaining Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice, MISSION-CJ, Maintaining Maintaining Independence and Sobriety through Systems Integration Outreach and Networking Peer Support, MISSION Peer Support
VA Office of Research and Development
Substance Use Disorder, Mental Health Disorder, Homelessness
08/25
08/25
POLAR, NCT04372953 / ACTRN12618001686291: Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The Trial).

Recruiting
N/A
906
Europe, US, RoW
Positive End-Expiratory Pressure (PEEP)
Murdoch Childrens Research Institute, University of Pennsylvania, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Oxford
Lung Injury, Preterm Birth
11/26
05/28
Looze, Ferdinandus de
NCT06153693: Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Completed
3
1083
Europe, Canada, US, RoW
Placebo, lorundrostat Dose 1, lorundrostat Dose 2
Mineralys Therapeutics Inc.
Hypertension
12/24
01/25
NCT06389487: A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

Completed
3
1459
Europe, Canada, Japan, US, RoW
RSVPreF3 OA investigational vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
07/24
03/25
NCT06291857: A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Active, not recruiting
3
9320
RoW
CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant, COVID-19 and influenza combination, Novavax COVID-19 Vaccine, Novavax SARS-CoV-2 rS vaccine, tNIV Vaccine, Trivalent Nanoparticle Influenza Hemagglutinin Vaccine, Fluzone High Dose, Fluzone HD
Novavax
COVID-19
05/25
02/26
NCT04809376: Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

Active, not recruiting
2/3
602
US, RoW
Pentosan Polysulfate Sodium twice weekly, PPS twice weekly, Placebo (Sodium Chloride Injection, 0.9%), Placebo, Pentosan Polysulfate Sodium Fixed Dose, Fixed Dose, Pentosan Polysulfate Sodium once weekly, PPS once weekly
Paradigm Biopharmaceuticals USA (INC)
Osteoarthritis, Knee
10/24
01/25
NCT05216341: Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint

Completed
2
134
RoW
OLP-1002, Diluent (Placebo) - Only for Stage 2
OliPass Corporation, Novotech (Australia) Pty Limited
Osteoarthritis
09/23
09/23
NCT05960097: A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Completed
2
675
US, RoW
CV0701 Bivalent High dose, CV0701 Bivalent Medium dose, CV0701 Bivalent Low dose, CV0601 Monovalent High dose, Control vaccine, CV0801 Monovalent
GlaxoSmithKline, CureVac
SARS-CoV-2
08/24
08/24
CHAPPII, NCT05942911: Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis

Suspended
2
20
RoW
IHL-675A, Cannabidiol, CBD, Epidiolex, Epydiolex, Hydroxychloroquine, HCQ, Plaquenil, Placebo
Incannex Healthcare Ltd
Rheumatoid Arthritis
10/24
10/25
NCT06491446: Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Recruiting
1/2
160
RoW
ABI-2280
Antiva Biosciences
Human Papillomavirus Infection
05/25
02/26
Stuckey, Madeleine
NCT06491446: Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Recruiting
1/2
160
RoW
ABI-2280
Antiva Biosciences
Human Papillomavirus Infection
05/25
02/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith, Jennifer D
NCT03626688 / 2018-001187-33: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Recruiting
3
1000
Europe, Canada, US, RoW
Ralinepag, APD811, Placebo
United Therapeutics
PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease
12/25
12/25
NCT04809376: Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

Active, not recruiting
2/3
602
US, RoW
Pentosan Polysulfate Sodium twice weekly, PPS twice weekly, Placebo (Sodium Chloride Injection, 0.9%), Placebo, Pentosan Polysulfate Sodium Fixed Dose, Fixed Dose, Pentosan Polysulfate Sodium once weekly, PPS once weekly
Paradigm Biopharmaceuticals USA (INC)
Osteoarthritis, Knee
10/24
01/25
ASLAN004-003, NCT05158023: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Completed
2
302
Europe, Canada, US, RoW
Placebo Comparator, ASLAN004
ASLAN Pharmaceuticals
Atopic Dermatitis
06/23
09/23
NCT05399368: An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

Terminated
2
229
Canada, US
RPT193, Placebo
RAPT Therapeutics, Inc.
Atopic Dermatitis
05/24
05/24
MACAWS, NCT06354751: Maternity Care Experiences of Asylum-seeking and Refugee Women in Scotland

Recruiting
N/A
300
Europe
University of Aberdeen
Refugee, Asylum-seeking Women, Maternity
04/25
11/26
NCT06662279: Hyrax Vs. Invisalign Palatal Expander Clinical Study

Recruiting
N/A
36
US
Removable Rapid Palatal Expander, Banded Palatal Expander
Align Technology, Inc.
Malocclusions, Narrow Maxilla, Narrow Maxillary Arch, Crowding
11/25
01/26
MISSION-CJ, NCT04523337: for Justice-Involved Homeless Veterans

Active, not recruiting
N/A
134
US
Maintaining Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice, MISSION-CJ, Maintaining Maintaining Independence and Sobriety through Systems Integration Outreach and Networking Peer Support, MISSION Peer Support
VA Office of Research and Development
Substance Use Disorder, Mental Health Disorder, Homelessness
08/25
08/25
POLAR, NCT04372953 / ACTRN12618001686291: Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The Trial).

Recruiting
N/A
906
Europe, US, RoW
Positive End-Expiratory Pressure (PEEP)
Murdoch Childrens Research Institute, University of Pennsylvania, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Oxford
Lung Injury, Preterm Birth
11/26
05/28
Looze, Ferdinandus de
NCT06153693: Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Completed
3
1083
Europe, Canada, US, RoW
Placebo, lorundrostat Dose 1, lorundrostat Dose 2
Mineralys Therapeutics Inc.
Hypertension
12/24
01/25
NCT06389487: A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

Completed
3
1459
Europe, Canada, Japan, US, RoW
RSVPreF3 OA investigational vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
07/24
03/25
NCT06291857: A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Active, not recruiting
3
9320
RoW
CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant, COVID-19 and influenza combination, Novavax COVID-19 Vaccine, Novavax SARS-CoV-2 rS vaccine, tNIV Vaccine, Trivalent Nanoparticle Influenza Hemagglutinin Vaccine, Fluzone High Dose, Fluzone HD
Novavax
COVID-19
05/25
02/26
NCT04809376: Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

Active, not recruiting
2/3
602
US, RoW
Pentosan Polysulfate Sodium twice weekly, PPS twice weekly, Placebo (Sodium Chloride Injection, 0.9%), Placebo, Pentosan Polysulfate Sodium Fixed Dose, Fixed Dose, Pentosan Polysulfate Sodium once weekly, PPS once weekly
Paradigm Biopharmaceuticals USA (INC)
Osteoarthritis, Knee
10/24
01/25
NCT05216341: Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint

Completed
2
134
RoW
OLP-1002, Diluent (Placebo) - Only for Stage 2
OliPass Corporation, Novotech (Australia) Pty Limited
Osteoarthritis
09/23
09/23
NCT05960097: A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Completed
2
675
US, RoW
CV0701 Bivalent High dose, CV0701 Bivalent Medium dose, CV0701 Bivalent Low dose, CV0601 Monovalent High dose, Control vaccine, CV0801 Monovalent
GlaxoSmithKline, CureVac
SARS-CoV-2
08/24
08/24
CHAPPII, NCT05942911: Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis

Suspended
2
20
RoW
IHL-675A, Cannabidiol, CBD, Epidiolex, Epydiolex, Hydroxychloroquine, HCQ, Plaquenil, Placebo
Incannex Healthcare Ltd
Rheumatoid Arthritis
10/24
10/25
NCT06491446: Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Recruiting
1/2
160
RoW
ABI-2280
Antiva Biosciences
Human Papillomavirus Infection
05/25
02/26
Stuckey, Madeleine
NCT06491446: Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Recruiting
1/2
160
RoW
ABI-2280
Antiva Biosciences
Human Papillomavirus Infection
05/25
02/26

Download Options